Related Experiment Videos
Diagnosis and therapy of tuberculous meningitis in children
Nicola Principi1, Susanna Esposito
1Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milan, Italy. nicola.principi@unimi.it
Insights
Tuberculous meningitis (TBM) in children has high mortality and severe neurological issues. Early diagnosis and aggressive treatment are vital, but more research is needed for optimal pediatric TBM care.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Tuberculous meningitis (TBM) disproportionately affects children, often leading to severe neurological sequelae and high mortality rates.
- Despite antibiotic treatment, 50% of survivors experience long-term neurological deficits, highlighting treatment challenges.
- Optimal diagnostic methods, drug regimens, and adjunctive therapies for pediatric TBM remain debated.
Purpose of the Study:
- To review current knowledge on the diagnosis and treatment of pediatric tuberculous meningitis.
- To identify critical gaps in understanding and to advocate for improved management strategies.
- To emphasize the urgent need for further research specifically in pediatric TBM.
Main Methods:
- This study is a comprehensive literature review.
- It synthesizes existing data on diagnostic approaches for pediatric TBM.
- It analyzes current treatment guidelines and adjunctive therapies.
Main Results:
- Pediatric TBM presents significant diagnostic and therapeutic challenges compared to adults.
- Mortality remains high (around 30% in severe cases), with substantial rates of neurological impairment in survivors.
- Evidence supporting adjunctive therapies like steroids and neurosurgery is not definitively established.
Conclusions:
- Aggressive diagnostic and therapeutic approaches are necessary for suspected pediatric TBM.
- Further research is urgently required to refine diagnostic tools and treatment protocols for children.
- Improved understanding and management are crucial to reduce the devastating impact of TBM in pediatric populations.
Abstract:
Children are among the subjects most frequently affected by tuberculous meningitis (TBM) due to their relative inability to contain primary Mycobacterium tuberculosis infection in the lung. TBM is a devastating disease with about 30% mortality among the most severe cases; moreover, 50% of survivors have neurological sequelae despite an apparently adequate administration of antibiotics. Early diagnosis and prompt treatment are crucial for reducing the risk of a poor outcome. However, especially in children, the best and most rapid way to confirm the diagnosis is controversial; the optimal choice, dose, and treatment duration of anti-tuberculosis drugs are not precisely defined, and the actual importance of adjunctive therapies with steroids and neurosurgery has not been adequately demonstrated. This review is an effort to discuss present knowledge of the diagnosis and treatment of pediatric TBM in order to offer the best solution to address this dramatic disease. In conclusion, we stress that new studies in children are urgently needed because data in the early years of life are more debatable than those collected in adults. In the meantime, when treating a child with suspected TBM, the most aggressive attitude to diagnosis and therapy is necessary, because TBM is a devastating disease.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bacterial Meningitis I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...